National Institutes of Health: Endometriosis trials

The registry lists 13 Endometriosis studies with National Institutes of Health as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 3Phase 2 5Phase 3 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Botulinum Toxin for Pelvic Pain in Women With EndometriosisCompletedNCT01553201Phase 1/2Results posted
• Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive FunctioningCompletedNCT01468935
• Global Study of Women's HealthCompletedNCT00849173
• Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)Status unknownNCT00458458Phase 3
• Effects of Endometriosis on Bone Mineral DensityCompletedNCT00291278
• Medical Treatment of Endometriosis-Associated Pelvic PainCompletedNCT00229996Phase 3
• Effect of Rosiglitazone on Peritoneal Cytokines in Women With EndometriosisWithdrawnNCT00121953Phase 2/3
• Use of Rosiglitazone in the Treatment of EndometriosisTerminatedNCT00115661Phase 2
• Acupuncture for Women's Health ConditionsCompletedNCT00090389Phase 1
• Pelvic Pain in Women With EndometriosisCompletedNCT00073801
• Endometriosis : Traditional Medicine vs Hormone TherapyCompletedNCT00034047Phase 1/2
• Evaluation of Women With Endocrine and Reproductive-Related ConditionsTerminatedNCT00001850
• The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by EndometriosisCompletedNCT00001848Phase 2